EEF2K and Dravet syndrome: To investigate whether the eEF2K signaling is dysregulated in the brain of DS, we first assessed eEF2 phosphorylation (at the Thr56 site) as a readout of eEF2K activity in post mortem brain tissue of patients with DS and age‐matched controls (provided by the NIH Neurobiobank) using Western blot.